DLCIG
CERE

D.L. Carlson Investment Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,500
Closed -$322K 146
2023
Q4
$322K Buy
+7,500
New +$322K 0.07% 119